GlassScriptPhysician profile
Ahmad Muhammad
NPI 1225713076
$1,037.01
in general payments reported to CMS, 2019-2025
10 companies · $1,037 in 2025
The $1,037 reported for 2025 was more than what 88% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,037.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $969.01 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $287.37 | 2025 | Erleada, Carvykti, Rybrevant |
| Convatec INC. | $154.23 | 2025 | |
| Immunitybio, INC. | $152.86 | 2025 | |
| Teleflex LLC | $143.53 | 2025 | Barrigel |
| Bluewind Medical | $139.68 | 2025 | Revi |
| Sumitomo Pharma America, INC. | $62.07 | 2025 | Gemtesa |
| Urogen Pharma, INC. | $34.33 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $24.29 | 2025 | Lynparza |
| Merck Sharp & Dohme LLC | $22.59 | 2025 | Lynparza |
| Ferring Pharmaceuticals INC. | $16.06 | 2025 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmad Muhammad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.